Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans

Beta Bionics NASDAQ: BBNX Chief Financial Officer Stephen Feider said the company's first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales coverage and growing confidence in the company's iLet insulin pump platform.